Cargando…

Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facility

Background: Eldecalcitol (ELD) is an active vitamin D(3) analog that is widely used in Japan for the treatment of osteoporosis. The most common adverse drug reaction of ELD is hypercalcemia. However, few reports have focused on acute kidney injury (AKI) associated with ELD-induced hypercalcemia. Mat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aihara, Seishi, Yamada, Shunsuke, Oka, Hideaki, Kamimura, Taro, Nakano, Toshiaki, Tsuruya, Kazuhiko, Harada, Atsumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442105/ https://www.ncbi.nlm.nih.gov/pubmed/30909788 http://dx.doi.org/10.1080/0886022X.2019.1578667

Ejemplares similares

Severe Hypocalcemia and Resulting Seizure Caused by Vitamin D Deficiency in an Older Patient Receiving Phenytoin: Eldecalcitol and Maxacalcitol Ointment as Potential Therapeutic Options for Hypocalcemia
por: Aihara, Seishi, et al.
Publicado: (2019)

Cholesterol Crystal Embolism Induced by Direct Factor Xa Inhibitor: A First Case Report
por: Oka, Hideaki, et al.
Publicado: (2017)

Eldecalcitol for the treatment of osteoporosis
por: Noguchi, Yuko, et al.
Publicado: (2013)

Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
por: Kamimura, Mikio, et al.
Publicado: (2019)

Hypercalcemia and large abdominal mass
por: Neild, G. H., et al.
Publicado: (2011)

Overview of the clinical efficacy and safety of eldecalcitol for the treatment of osteoporosis
por: Cui, Lijia, et al.
Publicado: (2022)

Emerging cross-talks between chronic kidney disease–mineral and bone disorder (CKD–MBD) and malnutrition–inflammation complex syndrome (MICS) in patients receiving dialysis
por: Yamada, Shunsuke, et al.
Publicado: (2022)

Safety and Efficacy of Zoledronic Acid Treatment with and without Acetaminophen and Eldecalcitol for Osteoporosis
por: Mochizuki, Takeshi, et al.
Publicado: (2021)

Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
por: Liu, Hongyan, et al.
Publicado: (2022)

Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis
por: Hagino, Hiroshi, et al.
Publicado: (2012)

Comparison of the Effects of Native Vitamin D and Eldecalcitol on Muscular Strength and Dynamic Balance in Patients with Postmenopausal Osteoporosis
por: Miyakoshi, Naohisa, et al.
Publicado: (2020)

Effects of eldecalcitol and ibandronate on secondary osteoporosis and muscle wasting in rats with adjuvant-induced arthritis
por: Ono, Yuichi, et al.
Publicado: (2018)

Eldecalcitol, an active vitamin D analog, effectively prevents cyclophosphamide-induced osteoporosis in rats
por: Wang, Wei, et al.
Publicado: (2019)

Geriatric Nutritional Risk Index (GNRI) and Creatinine Index Equally Predict the Risk of Mortality in Hemodialysis Patients: J-DOPPS
por: Yamada, Shunsuke, et al.
Publicado: (2020)

Effects of monthly minodronate with or without eldecalcitol addition in osteoporosis patients with rheumatoid arthritis: An 18-month prospective study
por: Suzuki, Takako, et al.
Publicado: (2019)

Two-year effectiveness of zoledronic acid with or without eldecalcitol in Japanese patients with osteoporosis: A randomized prospective study
por: Mochizuki, Takeshi, et al.
Publicado: (2022)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Human hepatic metabolism of the anti-osteoporosis drug eldecalcitol involves sterol C4-methyl oxidase
por: Yasuda, Kaori, et al.
Publicado: (2015)

Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

The Synergistic Effect of Zuogui Pill and Eldecalcitol on Improving Bone Mass and Osteogenesis in Type 2 Diabetic Osteoporosis
por: Shi, Tuo, et al.
Publicado: (2023)

Sex differences in the 10-year survival of patients undergoing maintenance hemodialysis in the Q-Cohort Study
por: Tsujikawa, Hiroaki, et al.
Publicado: (2022)

Increased Risk of Infection-Related and All-Cause Death in Hypercalcemic Patients Receiving Hemodialysis: The Q-Cohort Study
por: Yamada, Shunsuke, et al.
Publicado: (2020)

Magnesium inhibits peritoneal calcification as a late-stage characteristic of encapsulating peritoneal sclerosis
por: Aihara, Seishi, et al.
Publicado: (2023)

Modified creatinine index and risk for long-term infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-Cohort Study
por: Arase, Hokuto, et al.
Publicado: (2020)

Eldecalcitol prevented OVX-induced osteoporosis through inhibiting BMSCs senescence by regulating the SIRT1-Nrf2 signal
por: Kou, Yuying, et al.
Publicado: (2023)

Serum Alkaline Phosphatase Levels and Increased Risk of Brain Hemorrhage in Hemodialysis Patients: The Q-Cohort Study
por: Kitamura, Hiromasa, et al.
Publicado: (2022)

Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials
por: Xu, Zhixing, et al.
Publicado: (2016)

Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
por: Tanaka, Mizue, et al.
Publicado: (2017)

Low intake of β carotene and dietary fiber from vegetables and fruits in patients with chronic kidney disease
por: Nakano, Toshiaki, et al.
Publicado: (2022)

Malnutrition-Inflammation Complex Syndrome and Bone Fractures and Cardiovascular Disease Events in Patients Undergoing Hemodialysis: The Q-Cohort Study
por: Yamada, Shunsuke, et al.
Publicado: (2022)

Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol
por: Nakamura, Toshitaka, et al.
Publicado: (2013)

Effects of eldecalcitol on cortical bone response to mechanical loading in rats
por: Yamasaki, Yusuke, et al.
Publicado: (2015)

Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo
por: Ye, Limin, et al.
Publicado: (2020)

Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials [Corrigendum]
Publicado: (2016)

Pharmacokinetic and Bioequivalence Study of Eldecalcitol Soft Capsules in Healthy Chinese Subjects
por: Li, Ting, et al.
Publicado: (2022)

Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD: The Fukuoka Kidney Disease Registry Study
por: Tanaka, Shigeru, et al.
Publicado: (2022)

Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Chronic Hemodialysis Patient
por: Yamada, Shunsuke, et al.
Publicado: (2012)

Short- and Long-term Effects of Dialysate Calcium Concentrations on Mineral and Bone Metabolism in Hemodialysis Patients: The K4 Study
por: Sakoh, Teppei, et al.
Publicado: (2019)

Clopidogrel-induced Eosinophilia with Hypercalcemia
por: Yamada, Kazuhiro, et al.
Publicado: (2022)

Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
por: Iwamoto, Jun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3rgggt1un1ndaak63lg8h56kee